Peptide selection for human immunodeficiency virus type 1 CTL-based vaccine evaluation.
暂无分享,去创建一个
Peter B Gilbert | Lawrence Corey | Steven G Self | S. Self | J. McElrath | P. Gilbert | L. Corey | Fusheng Li | U. Malhotra | A. Duerr | Fusheng Li | Uma Malhotra | Natalie R Hawkins | Ann C Duerr | Juliana M McElrath | Natalie R. Hawkins
[1] A Sette,et al. The development of multi-epitope vaccines: epitope identification, vaccine design and clinical evaluation. , 2001, Biologicals : journal of the International Association of Biological Standardization.
[2] J. Margolick,et al. Improved Coreceptor Usage Prediction and GenotypicMonitoring of R5-to-X4 Transition by Motif Analysis of HumanImmunodeficiency Virus Type 1 env V3 LoopSequences , 2003, Journal of Virology.
[3] D. Anthony,et al. T-cell epitope mapping using the ELISPOT approach. , 2003, Methods.
[4] S. Henikoff,et al. Amino acid substitution matrices from protein blocks. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[5] G. Nabel,et al. Immunogenicity of Multiple Gene and Clade Human Immunodeficiency Virus Type 1 DNA Vaccines , 2003, Journal of Virology.
[6] A. Sette,et al. Recognition of Variant HIV-1 Epitopes from Diverse Viral Subtypes by Vaccine-Induced CTL1 , 2004, The Journal of Immunology.
[7] Henryk Mach,et al. Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity , 2002, Nature.
[8] R. Spang,et al. Estimating amino acid substitution models: a comparison of Dayhoff's estimator, the resolvent approach and a maximum likelihood method. , 2002, Molecular biology and evolution.
[9] M. Mulligan,et al. CD8 T-cell responses in early HIV-1 infection are skewed towards high entropy peptides , 2005, AIDS.
[10] F. Vannberg,et al. Human Immunodeficiency Virus Type 1 Subtype C Molecular Phylogeny: Consensus Sequence for an AIDS Vaccine Design? , 2002, Journal of Virology.
[11] A. Sette,et al. Early Induction and Maintenance of Env-Specific T-Helper Cells following Human Immunodeficiency Virus Type 1 Infection , 2003, Journal of Virology.
[12] T. Ndung’u,et al. Magnitude and Frequency of Cytotoxic T-Lymphocyte Responses: Identification of Immunodominant Regions of Human Immunodeficiency Virus Type 1 Subtype C , 2002, Journal of Virology.
[13] James G. Herndon,et al. Control of a Mucosal Challenge and Prevention of AIDS by a Multiprotein DNA/MVA Vaccine , 2001, Science.
[14] A. McMichael,et al. HIV vaccines 1983–2003 , 2003, Nature Medicine.
[15] P. Allen,et al. Tickling the TCR: selective T-cell functions stimulated by altered peptide ligands. , 1993, Immunology today.
[16] S. Zolla-Pazner,et al. Immunoreactivity of Intact Virions of Human Immunodeficiency Virus Type 1 (HIV-1) Reveals the Existence of Fewer HIV-1 Immunotypes than Genotypes , 2000, Journal of Virology.
[17] Søren Brunak,et al. Clustering Patterns of Cytotoxic T-Lymphocyte Epitopes in Human Immunodeficiency Virus Type 1 (HIV-1) Proteins Reveal Imprints of Immune Evasion on HIV-1 Global Variation , 2002, Journal of Virology.
[18] Vladimir Brusic,et al. MHCPEP, a database of MHC-binding peptides: update 1996 , 1997, Nucleic Acids Res..
[19] Feng Gao,et al. Diversity Considerations in HIV-1 Vaccine Selection , 2002, Science.
[20] Anne S De Groot,et al. Bioinformatics tools for identifying class I-restricted epitopes. , 2003, Methods.
[21] J. Shiver,et al. Heterologous Human Immunodeficiency Virus Type 1 Priming-Boosting Immunization Strategies Involving Replication-Defective Adenovirus and Poxvirus Vaccine Vectors , 2004, Journal of Virology.
[22] J. Reidhaar-Olson,et al. The use of bioinformatics for identifying class II-restricted T-cell epitopes. , 2003, Methods.
[23] M. McElrath,et al. Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection. , 1997, The New England journal of medicine.
[24] Lawrence Corey,et al. Comprehensive Analysis of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific Gamma Interferon-Secreting CD8+ T Cells in Primary HIV-1 Infection , 2003, Journal of Virology.
[25] Todd M. Allen,et al. Enhanced Detection of Human Immunodeficiency Virus Type 1-Specific T-Cell Responses to Highly Variable Regions by Using Peptides Based on Autologous Virus Sequences , 2003, Journal of Virology.
[26] S. Zolla-Pazner,et al. Immunotyping of Human Immunodeficiency Virus Type 1 (HIV): an Approach to Immunologic Classification of HIV , 1999, Journal of Virology.
[27] A. Simon,et al. Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination. , 2000, Science.
[28] Peter Walden,et al. Exact prediction of a natural T cell epitope , 1991, European journal of immunology.
[29] A. Osterhaus,et al. Mismatch between the 1997/1998 influenza vaccine and the major epidemic A(H3N2) virus strain as the cause of an inadequate vaccine‐induced antibody response to this strain in the elderly , 2000, Journal of medical virology.
[30] M. Altfeld,et al. Comparison of overlapping peptide sets for detection of antiviral CD8 and CD4 T cell responses. , 2003, Journal of immunological methods.
[31] W. Heneine,et al. Multiprotein HIV type 1 clade B DNA/MVA vaccine: construction, safety, and immunogenicity in Macaques. , 2004, AIDS research and human retroviruses.
[32] D. Purcell,et al. Vaccines and vaccine strategies against HIV. , 2004, Current drug targets.
[33] Lawrence Corey,et al. Biological and Virologic Characteristics of Primary HIV Infection , 1998, Annals of Internal Medicine.
[34] D. Nickle,et al. Consensus and Ancestral State HIV Vaccines , 2003, Science.
[35] D. Montefiori,et al. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. , 1999, Science.